ITMI960378A0 - - Google Patents

Info

Publication number
ITMI960378A0
ITMI960378A0 ITMI960378A ITMI960378A ITMI960378A0 IT MI960378 A0 ITMI960378 A0 IT MI960378A0 IT MI960378 A ITMI960378 A IT MI960378A IT MI960378 A ITMI960378 A IT MI960378A IT MI960378 A0 ITMI960378 A0 IT MI960378A0
Authority
IT
Italy
Application number
ITMI960378A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11373430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI960378(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to IT96MI000378A priority Critical patent/IT1282705B1/it
Publication of ITMI960378A0 publication Critical patent/ITMI960378A0/it
Priority to ES97906125T priority patent/ES2213205T3/es
Priority to DK97906125T priority patent/DK0906100T3/da
Priority to AU20932/97A priority patent/AU2093297A/en
Priority to JP53057997A priority patent/JP2001511763A/ja
Priority to PT97906125T priority patent/PT906100E/pt
Priority to PCT/EP1997/000897 priority patent/WO1997031637A1/en
Priority to EP97906125A priority patent/EP0906100B1/en
Priority to DE69727378T priority patent/DE69727378T2/de
Priority to AT97906125T priority patent/ATE258438T1/de
Priority to US08/807,338 priority patent/US5990114A/en
Publication of ITMI960378A1 publication Critical patent/ITMI960378A1/it
Publication of IT1282705B1 publication Critical patent/IT1282705B1/it
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Spinning Or Twisting Of Yarns (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IT96MI000378A 1996-02-28 1996-02-28 Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria IT1282705B1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT96MI000378A IT1282705B1 (it) 1996-02-28 1996-02-28 Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria
AT97906125T ATE258438T1 (de) 1996-02-28 1997-02-25 Verwendung von antagonisten des 5-htia rezeptors zur behandlung von harninkontinenz
PT97906125T PT906100E (pt) 1996-02-28 1997-02-25 Utilizacao de antagonistas do receptor 5-hta1 no tratamento da incontinencia urinaria
DK97906125T DK0906100T3 (da) 1996-02-28 1997-02-25 Anvendelse af 5-HT1A-receptorantagonister til behandling af urininkontinens
AU20932/97A AU2093297A (en) 1996-02-28 1997-02-25 Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence
JP53057997A JP2001511763A (ja) 1996-02-28 1997-02-25 尿失禁の治療のための５−ｈｔ▲下１ａ▼受容体アンタゴニストの使用
ES97906125T ES2213205T3 (es) 1996-02-28 1997-02-25 Uso de antagonistas del receptor 5-ht1a para el tratamiento de la incontinencia de orina.
PCT/EP1997/000897 WO1997031637A1 (en) 1996-02-28 1997-02-25 Use of 5-ht1a receptor antagonists for the treatment of urinary incontinence
EP97906125A EP0906100B1 (en) 1996-02-28 1997-02-25 Use of 5-ht 1a? receptor antagonists for the treatment of urinary incontinence
DE69727378T DE69727378T2 (de) 1996-02-28 1997-02-25 Verwendung von antagonisten des 5-htia rezeptors zur behandlung von harninkontinenz
US08/807,338 US5990114A (en) 1996-02-28 1997-02-28 Use of 5-HT1A receptor antagonists for the treatment of urinary incontinence

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI000378A IT1282705B1 (it) 1996-02-28 1996-02-28 Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria

Publications (3)

Publication Number Publication Date
ITMI960378A0 true ITMI960378A0 (OSRAM) 1996-02-28
ITMI960378A1 ITMI960378A1 (it) 1997-08-28
IT1282705B1 IT1282705B1 (it) 1998-03-31

Family

ID=11373430

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI000378A IT1282705B1 (it) 1996-02-28 1996-02-28 Uso di antagonisti del recettore serotoninergico 5-ht|a per il trattamento dell'incontinenza urinaria

Country Status (10)

Country Link
EP (1) EP0906100B1 (OSRAM)
JP (1) JP2001511763A (OSRAM)
AT (1) ATE258438T1 (OSRAM)
AU (1) AU2093297A (OSRAM)
DE (1) DE69727378T2 (OSRAM)
DK (1) DK0906100T3 (OSRAM)
ES (1) ES2213205T3 (OSRAM)
IT (1) IT1282705B1 (OSRAM)
PT (1) PT906100E (OSRAM)
WO (1) WO1997031637A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156780A (en) * 1996-10-17 2000-12-05 Milkhaus Laboratory, Inc. Treatment of fecal incontinence
SE510305C2 (sv) 1997-05-30 1999-05-10 Astra Ab Nytt salt
AU8130298A (en) * 1997-07-15 1999-02-10 Sankyo Company Limited Piperazine derivatives
US6906069B1 (en) 1999-01-08 2005-06-14 Amgen Inc. LXR modulators
WO2001060818A1 (en) * 2000-02-14 2001-08-23 Tularik Inc. Lxr modulators
US6673543B2 (en) 2000-04-05 2004-01-06 Tularik, Inc. Solid phase synthesis of LXR ligands
DK1392676T3 (da) * 2001-02-16 2007-04-10 Aventis Pharma Inc Hidtil ukendte heterocykliske urinstofderivater og deres anvendelse som dopamin -D3 - receptorligander
IL160852A0 (en) * 2001-09-27 2004-08-31 Pharmacia Ab Pharmaceutical compositions for the treatment of urinary disorders
WO2003063796A2 (en) 2002-01-30 2003-08-07 Tularik Inc. Heterocyclic arylsulfonamidobenzylic compounds
CL2004000826A1 (es) 2003-04-25 2005-03-04 Pfizer Uso de un agonista para el receptor 5-ht2c para preparar un medicamento util en el tratamiento de la incontinencia urinaria provocada por estres, con la condicion de que el agonista no sea 1-[6-cloro-5-(trifluorometil)-2-piridinil]piperazina (org-129
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
JPWO2006082872A1 (ja) * 2005-02-04 2008-06-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 １−（ピペリジン−４−イル）−１ｈ−インドール誘導体
JP4932717B2 (ja) 2005-05-11 2012-05-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピペリジン環を有するインドール誘導体の製造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU645681B2 (en) * 1991-05-02 1994-01-20 John Wyeth & Brother Limited Piperazine derivatives
SG65570A1 (en) * 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds
GB9411099D0 (en) * 1994-06-03 1994-07-27 Wyeth John & Brother Ltd Piperazine derivatives
GB9417135D0 (en) * 1994-08-23 1994-10-12 Medinnova S F Method

Also Published As

Publication number Publication date
ITMI960378A1 (it) 1997-08-28
ATE258438T1 (de) 2004-02-15
EP0906100B1 (en) 2004-01-28
WO1997031637A1 (en) 1997-09-04
AU2093297A (en) 1997-09-16
PT906100E (pt) 2004-06-30
DE69727378T2 (de) 2004-12-09
EP0906100A1 (en) 1999-04-07
DK0906100T3 (da) 2004-05-03
IT1282705B1 (it) 1998-03-31
DE69727378D1 (de) 2004-03-04
JP2001511763A (ja) 2001-08-14
ES2213205T3 (es) 2004-08-16

Similar Documents

Publication Publication Date Title
AR026660A2 (OSRAM)
BRPI9713914B8 (OSRAM)
ITMI960046A0 (OSRAM)
ITMI960553A0 (OSRAM)
BR7600721U (OSRAM)
BR7601346U (OSRAM)
BR9603859A (OSRAM)
CN3039060S (OSRAM)
CN3039213S (OSRAM)
CN3040024S (OSRAM)
CN3040367S (OSRAM)
CN3040543S (OSRAM)
CN3040805S (OSRAM)
CN3041207S (OSRAM)
CN3041374S (OSRAM)
CN3041383S (OSRAM)
CN3042193S (OSRAM)
CN3042289S (OSRAM)
CN3042589S (OSRAM)
CN3043305S (OSRAM)
CN3044168S (OSRAM)
CN3044346S (OSRAM)
CN3044347S (OSRAM)
CN3044348S (OSRAM)
CN3044349S (OSRAM)

Legal Events

Date Code Title Description
0001 Granted